Occurrence of hypokalemia in patients with new-onset atrial fibrillation presenting within 48 hours
DOI:
https://doi.org/10.59736/IJP.24.03.1114Keywords:
Atrial Fibrillation, Cardiac Arrhythmias, HypokalemiaAbstract
Background: Atrial fibrillation (AF) is the most common cardiac rhythm disorder. Various reversible conditions, particularly electrolyte abnormalities, may contribute to its development or persistence. Reduced serum potassium levels can influence cardiac electrical activity and myocardial repolarization, potentially increasing the propensity for atrial arrhythmias. This study was therefore undertaken to assess the frequency of hypokalemia among patients presenting with new-onset AF within 48 hours of symptom onset. This study was therefore undertaken to determine the frequency of hypokalemia among patients presenting with new-onset AF within 48 hours of symptom onset.
Methods: The study design was descriptive cross-sectional study at Fauji foundation hospital Peshawar. A total of 102 patients with new-onset atrial fibrillation, diagnosed on clinical and electrocardiographic assessment, were enrolled. The required sample size was calculated using the WHO Sample Size Calculator based on an anticipated hypokalemia proportion of 4.43%, a 4% margin of error, and a 5% level of significance. All participants underwent clinical assessment and serum electrolyte measurement. Hypokalemia was defined as a serum potassium concentration below 3.5 mmol/L.
Results: The mean age of the study population was 39.9 ± 16.22 years. The mean duration of presenting symptoms was 1.39 ± 0.49 hours, while the mean systolic blood pressure and body mass index were 139.9 ± 13.98 mmHg and 28.71 ± 6.82 kg/m², respectively. Among the 102 patients with new-onset atrial fibrillation, hypokalemia was identified in 7 patients (6.9%). Hypokalemia was significantly associated with higher body mass index (p=0.017), hypertension (p=0.013), and diabetes mellitus (p=0.011).
Conclusion: Hypokalemia identified in a proportion of patients presenting with new-onset atrial fibrillation was significantly associated with diabetes mellitus, hypertension, and increased body mass index. Assessment of routine potassium may be particularly important in these patients.
References
Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020;127(1):4-20. doi:10.1161/CIRCRESAHA.120.316340.
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-21.
Zulkifly H, Lip GYH, Lane DA. Epidemiology of atrial fibrillation. Int J ClinPract.2018;72(3). doi:10.1111/ijcp.13070.
Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136(6): 583-96.doi:10.1161/CIRCULATIONAHA.116.023163.
Tanaka Y, Shah NS, Passman R, Greenland P, Lloyd-Jones DM, Khan SS. Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018. J Am Heart Assoc. 2021;10(15). doi:10.1161/JAHA.120.020163.
Tazmini K, Frisk M, Lewalle A, Laasmaa M, Morotti S, Lipsett DB, et al. Hypokalemia promotes arrhythmia by distinct mechanisms in atrial and ventricular myocytes. Circ Res. 2020;126(7):889-906. doi:10.1161/CIRCRESAHA.119.315641.
Krijthe BP, Heeringa J, Kors JA, Hofman A, Franco OH, Witteman JCM, et al. Serum potassium levels and the risk of atrial fibrillation: The Rotterdam Study. Int J Cardiol.2013;168(6):5411-15.
doi: 10.1016/j.ijcard.2013.08.048.
Hagengaard L, Søgaard P, Espersen M, Sessa M, Lund PE, Krogager ML, et al. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother.2020;6(3):137-44. doi:10.1093/ehjcvp/pvz024.
Saxena N, Saxena S, Mathew C. Study of impact and association of serum potassium levels with the incidence of risk of atrial fibrillation. IAIM. 2020;7(2):1-5. URL:https://www.iaimjournal.com/storage/2020/02/iaim_2020_0702_01.pdf
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-88.
doi: 10.1161/01.STR.22.8.983.
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-25. doi: 10.1161/01.CIR.0000072767.89944.6E.
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation. 1998;98(10):946-52.
doi: 10.1161/01.CIR.98.10.946.
Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol.2004;43(2):155-61.
doi: 10.1016/j.jacc.2003.06.021.
Wahr JA, Parks R, Boisvert D, Comunale ME, Schechtman KB, Koval C, et al. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. JAMA. 1999;281(23):2203-10. doi:10.1001/jama.281.23.2203.
Auer J, Weber T, Berent R, Lamm G, Eber B. Serum potassium level and risk of postoperative atrial fibrillation in patients undergoing cardiac surgery. J Am Coll Cardiol.2004;44(4):938-39.
doi: 10.1016/j.jacc.2004.05.035.
Severi S, Pogliani D, Fantini G, Fabbrini P, Viganò MR, Galbiati E, et al. Alterations of atrial electrophysiology induced by electrolyte variations: combined computational and P-wave analysis. Europace.2010;12(6):842-49. doi:10.1093/europace/euq042.
Agarwal YK, Aronow WS, Levy JA, Spodick DH. Association of interatrial block with development of atrial fibrillation. Am J Cardiol. 2003;91(7):882. doi:10.1016/S0002-9149(03)00027-4.
Magnani JW, Johnson VM, Sullivan LM, Gorodeski EZ, Schnabel RB, Lubitz SA, et al. P wave duration and risk of longitudinal atrial fibrillation in persons ≥60 years old (from the Framingham Heart Study). Am J Cardiol. 2011;107(6):917-21. e1. doi: 10.1016/j.amjcard.2010.10.075.
Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J. 2000;139(5):814-19. doi:10.1016/S0002-8703(00)90012-7.
Weiss JN, Qu Z, Shivkumar K. Electrophysiology of hypokalemia and hyperkalemia. Circ Arrhythm Electrophysiol.2017;10(3). doi:10.1161/CIRCEP.116.004667.
Phillips CT, Wang J, Celi LA, Zhang Z, Feng M. Association of hypokalemia with an increased risk for medically treated arrhythmias. PLoS One. 2019;14(6). doi: 10.1371/journal.pone.0217432.
Cacioppo F, Reisenbauer D, Herkner H, Oppenauer J, Schuetz N, Niederdoeckl J, et al. Association of intravenous potassium and magnesium administration with spontaneous conversion of atrial fibrillation and atrial flutter in the emergency department. JAMA Netw Open.2022;5(10). doi:10.1001/jamanetworkopen.2022.37234
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Zeeshan Ahmad, Abdul Latif, Roomana Khawaja Khail, Ismail Khan, Taj Muhammad Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
